A. Boonstra

J. Marcus, P. Postmus, A. Boonstra, 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

ddition of Prostanoids in Pulmonary Hypertension eteriorating on Oral Therapy

J. Marcus, P. Postmus, A. Boonstra, 2022 .

Interventricular mechanical asynchrony due to right ventricular pressure overload in pulmonary hypertension plays an important role in impaired left ventricular filling.

J. Marcus, P. Postmus, A. Boonstra, 2005, Chest.

Right ventricular reverse remodelling after sildenafil in pulmonary arterial hypertension

J. Bronzwaer, J. Marcus, P. Postmus, 2006, Heart.

Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension.

O. Kamp, J. Twisk, M. Schalij, 2009, The American journal of cardiology.

Collaboration Around Rare Bone Diseases Leads to the Unique Organizational Incentive of the Amsterdam Bone Center

W. Lems, G. Pals, A. Lammertsma, 2020, Frontiers in Endocrinology.

Cardiac shunt in COPD as a cause of severe hypoxaemia: probably not so uncommon after all

N. Westerhof, P. Postmus, B. Boerrigter, 2011, European Respiratory Journal.

IV Different right ventricular contractility in limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension

J. Bronzwaer, N. Westerhof, E. Smit, 2010 .

Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension

B. Dijkmans, J. Bronzwaer, N. Westerhof, 2008, European Respiratory Journal.

Sildenafil treatment in COPD does not affect stroke volume or exercise capacity

N. Westerhof, J. Marcus, P. Postmus, 2008, European Respiratory Journal.

Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition.

B. Mulder, A. Boonstra, A. Vonk-Noordegraaf, 2007, Congenital heart disease.

Cardiopulmonary Exercise Test Characteristics in Patients with Chronic Obstructive Pulmonary Disease and Associated Pulmonary Hypertension

P. Postmus, H. Bogaard, A. Boonstra, 2007, Respiration.

Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients.

J. Bronzwaer, W. Paulus, J. Marcus, 2007, Chest.

Risk Factors for Hemoptysis in Idiopathic and Hereditary Pulmonary Arterial Hypertension

B. Boerrigter, H. Bogaard, A. Boonstra, 2013, PloS one.

Right ventricular oscillatory power is a constant fraction of total power irrespective of pulmonary artery pressure.

N. Westerhof, J. Marcus, P. Postmus, 2010, American journal of respiratory and critical care medicine.

Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.

M. Humbert, P. Postmus, E. Fadel, 2012, American journal of respiratory and critical care medicine.

Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy

B. Dijkmans, E. Smit, P. Postmus, 2009, European Respiratory Journal.

Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses

N. Westerhof, E. Nossent, H. Bogaard, 2013, European Respiratory Journal.

Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension

M. Humbert, B. Girerd, D. Montani, 2013, European Respiratory Journal.

A comparison of noninvasive MRI‐based methods of estimating pulmonary artery pressure in pulmonary hypertension

J. Bronzwaer, J. Marcus, P. Postmus, 2005, Journal of magnetic resonance imaging : JMRI.

Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension

M. Huisman, A. Boonstra, A. Vonk-Noordegraaf, 2012, European Respiratory Journal.

Platelet-derived growth factor receptor-b and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study

B. Dijkmans, E. Smit, W. Mooi, 2011 .

Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study

B. Dijkmans, E. Smit, W. Mooi, 2011, Arthritis research & therapy.

Right coronary artery flow impairment in patients with pulmonary hypertension.

J. Bronzwaer, N. Westerhof, J. Marcus, 2007, European heart journal.

Persistent exercise intolerance after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

J. Marcus, E. Nossent, P. Symersky, 2020, European Respiratory Journal.

829 Care Organisation for Pulmonary Arterial Hypertension in Developed Countries: A Survey

A. Torbicki, R. Speich, S. Orfanos, 2012 .

Maximum rate of oxygen consumption related to succinate dehydrogenase activity in skeletal muscle fibres of chronic heart failure patients and controls

W. van Mechelen, A. Boonstra, W. J. van der Laarse, 2003, Clinical physiology and functional imaging.

VI Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension

A. Voskuyl, A. Boonstra, A. Vonk-Noordegraaf, 2010 .

A review of pulmonary arterial hypertension: Part 2: Current and expected treatments.

J. Bronzwaer, P. Postmus, A. Noordegraaf, 2004, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Possible role of imatinib in clinical pulmonary veno-occlusive disease

E. Smit, G. Amerongen, A. Boonstra, 2008, European Respiratory Journal.

Low complication rates with totally implantable access port use in epoprostenol treatment of pulmonary hypertension.

R. Snijder, A. Boonstra, A. Vonk-Noordegraaf, 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Iron deficiency is common in idiopathic pulmonary arterial hypertension

N. Westerhof, P. Postmus, A. Boonstra, 2010, European Respiratory Journal.

IX R ESTING HEART RATE REFLECTS PROGNOSIS IN PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION

J., O. Kamp, A. Noordegraaf, 2008 .

ELECTROCARDIOGRAPHIC MONITORING OF TREATMENT RESPONSE IN PULMONARY ARTERIAL HYPERTENSION PATIENTS

J., O. Kamp, É., 2008 .

NT-proBNP reflects right ventricular structure and function in pulmonary hypertension

J. Marcus, J. Twisk, P. Postmus, 2006, European Respiratory Journal.

Right ventricular-arterial coupling in patients with pulmonary arterial hypertension

N. Westerhof, M. L. Handoko, A. Noordegraaf, 2015 .

No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial

O. Kamp, R. IJzerman, Y. Smulders, 2010, BMC pulmonary medicine.

Noninvasive follow-up strategy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

M. L. Handoko, E. Nossent, P. Tuinman, 2022, ERJ Open Research.

Non-invasive follow-up strategy after pulmonary endarterectomy for CTEPH

M. L. Handoko, E. Nossent, P. Tuinman, 2022, ERJ Open Research.

Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension.

N. Westerhof, P. Postmus, B. Boerrigter, 2012, Chest.

Prognostic Relevance of Changes in Exercise Test Variables in Pulmonary Arterial Hypertension

N. Westerhof, H. Bogaard, A. Boonstra, 2013, PloS one.

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.

M. Humbert, J. Barberà, S. Rosenkranz, 2020, Respiratory medicine.

Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension.

N. Westerhof, J. Twisk, P. Postmus, 2009, Respiratory medicine.

EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension.

J. Granton, E. Bergot, G. Simonneau, 2014, American heart journal.

Single arterial occlusion to locate resistance in patients with pulmonary hypertension

R. Naeije, P. Fesler, L. Rubin, 2003, European Respiratory Journal.

Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung

P. Postmus, R. Roeleveld, A. Boonstra, 2003, European Respiratory Journal.

[Pulmonary arterial hypertension due to the use of amphetamines as drugs or doping].

P. Postmus, A. Boonstra, A. Vonk Noordegraaf, 2005, Nederlands tijdschrift voor geneeskunde.

Release of C-Reactive Protein by Stenting

P. Postmus, A. Boonstra, A. Vonk-Noordegraaf, 2006 .

Genetic counselling for pulmonary arterial hypertension: a matter of variable variability

J. Gille, A. Boonstra, A. Vonk Noordegraaf, 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Non-invasive stroke volume assessment in patients with pulmonary arterial hypertension: left-sided data mandatory

N. Westerhof, J. Marcus, P. Postmus, 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

Effects Of Inhaled Aviptadil (Vasoactive Intestinal Peptide) In Patients With Pulmonary Arterial Hypertension (PAH)

J. Barberà, A. Torbicki, R. Ewert, 2010, ATS 2010.

Epoprostenol-induced pulmonary vasodilatation in patients with pulmonary hypertension measured by electrical impedance tomography.

J. Bronzwaer, P. Postmus, P. de Vries, 2002, Physiological measurement.

Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension.

J. Bronzwaer, J. Marcus, P. Postmus, 2004, Chest.

Clinically significant change in stroke volume in pulmonary hypertension.

J. Bronzwaer, N. Westerhof, J. Marcus, 2011, Chest.

The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension.

J. Marcus, M. Heymans, H. Bogaard, 2014, Chest.

Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases

A. Gabrielli, C. Denton, G. Riemekasten, 2007, Annals of the rheumatic diseases.

Impaired left ventricular filling due to right ventricular pressure overload in primary pulmonary hypertension: noninvasive monitoring using MRI.

J. Marcus, R. Heethaar, A. van Rossum, 2001, Chest.

Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension

N. Westerhof, J. Marcus, M. L. Handoko, 2015, European Respiratory Journal.

RC time constant of single lung equals that of both lungs together: a study in chronic thromboembolic pulmonary hypertension.

B. Westerhof, N. Westerhof, J. Marcus, 2009, American journal of physiology. Heart and circulatory physiology.

Exercise testing to estimate survival in pulmonary hypertension.

P. Postmus, M. Spreeuwenberg, H. Bogaard, 2008, Medicine and science in sports and exercise.

Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension

M. Heymans, H. Bogaard, A. Boonstra, 2015, European Respiratory Journal.

Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Nico Westerhof, Taco Kind, Anton Vonk-Noordegraaf, 2011, Journal of the American College of Cardiology.

Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

J. Bronzwaer, J. Marcus, P. Postmus, 2007, European heart journal.

Stroke volume response during exercise measured by acetylene uptake and MRI

Anton Vonk-Noordegraaf, J. Marcus, P. Postmus, 2007, Physiological measurement.

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2

M. Humbert, R. Barst, G. Simonneau, 2004, European Respiratory Journal.

Long-term outcomes in pulmonary arterial hypertension in the first-line epoprostenol or first-line bosentan era.

P. Postmus, A. Boonstra, A. Vonk Noordegraaf, 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Effects of exercise training in patients with idiopathic pulmonary arterial hypertension

N. Westerhof, J. Twisk, A. J. van ‘t Hul, 2009, European Respiratory Journal.

Supine-exercise-induced oxygen supply to the right myocardium is attenuated in patients with severe idiopathic pulmonary arterial hypertension

N. Westerhof, J. Marcus, M. Lubberink, 2011, Heart.

ECG monitoring of treatment response in pulmonary arterial hypertension patients.

O. Kamp, J. Twisk, M. Schalij, 2008, Chest.

Determinants of pulmonary perfusion measured by electrical impedance tomography

J. Marcus, P. Postmus, P. Vries, 2004, European Journal of Applied Physiology.

Pulmonary vascular responses to hypoxia and hyperoxia in healthy volunteers and COPD patients measured by electrical impedance tomography.

Anton Vonk-Noordegraaf, J. Marcus, P. Postmus, 2003, Chest.

Electrical impedance tomography to measure pulmonary perfusion: is the reproducibility high enough for clinical practice?

T. Faes, P. Postmus, M. L. Handoko, 2003, Physiological measurement.

Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

E. Smit, A. Voskuyl, A. Boonstra, 2010, International journal of rheumatology.

Chapter 6 A clinical prediction rule to non-invasively identify left-sided heart failure in a population suspected of pulmonary arterial hypertension

A. Rossum, A. Noordegraaf, H. Bogaard, 2014 .

Noninvasive assessment and monitoring of the pulmonary circulation

J. Marcus, P. Postmus, A. Peacock, 2005, European Respiratory Journal.

Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension

L. Beenen, L. Kroft, E. Nossent, 2021, European Respiratory Journal.

A New Clinical Phenotype with Non-Plexiform Vasculopathy and Distinctive Microvessel Remodeling Among Idiopathic Pulmonary Arterial Hypertension Patients

P. Dorfmüller, E. Nossent, A. Boonstra, 2022, D96. EMBARCADERO: MACHINES AND DEEP PHENOTYPING OF THE PULMONARY CIRCULATION.

Right Ventricular Function During Exercise After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension.

M. L. Handoko, E. Nossent, P. Symersky, 2023, Journal of the American Heart Association.

Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension.

N. Westerhof, J. Marcus, M. Heymans, 2015, Chest.

Hemodynamic Effects of Pulmonary Arterial Hypertension-Specific Therapy in Patients With Heart Failure With Preserved Ejection Fraction and With Combined Post- and Precapillay Pulmonary Hypertension

J. Marcus, M. L. Handoko, E. Nossent, 2020 .

Depression of force production and ATPase activity in different types of human skeletal muscle fibers from patients with chronic heart failure.

P. Szentesi, F. Visser, A. Boonstra, 2005, Journal of applied physiology.

Right Ventricular Failure in Idiopathic Pulmonary Arterial Hypertension Is Associated With Inefficient Myocardial Oxygen Utilization

N. Westerhof, J. Marcus, M. Lubberink, 2011, Circulation. Heart failure.

Sarcoplasmic reticulum ATPase activity in type I and II skeletal muscle fibres of chronic heart failure patients.

W. van Mechelen, F. Visser, A. Boonstra, 2009, International journal of cardiology.

Myoglobin concentration in skeletal muscle fibers of chronic heart failure patients.

Willem van Mechelen, W. van Mechelen, A. Boonstra, 2009, Journal of applied physiology.

Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling.

J. Zwanenburg, J. Marcus, M. Götte, 2008, Journal of the American College of Cardiology.

Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension.

Nico Westerhof, Jan-Willem Lankhaar, Anton Vonk-Noordegraaf, 2008, European heart journal.

EPITOME-2, An Open-Label Study Evaluating A New Formulation Of Epoprostenol Sodium In Pulmonary Arterial Hypertension Patients Switched From Flolan®

J. Granton, E. Bergot, G. Simonneau, 2012, ATS 2012.

Persistent exercise intolerance after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

J. Marcus, E. Nossent, P. Symersky, 2020, European Respiratory Journal.

Systolic pulmonary artery pressure and heart rate are main determinants of oxygen consumption in the right ventricular myocardium of patients with idiopathic pulmonary arterial hypertension

N. Westerhof, J. Marcus, M. Lubberink, 2011, European journal of heart failure.

Pulmonary hypertension: diagnosis, differential diagnosis and pitfalls.

A. Torbicki, E. Nossent, A. Noordegraaf, 2012 .

Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension.

Nico Westerhof, Jan-Willem Lankhaar, Anton Vonk-Noordegraaf, 2006, American journal of physiology. Heart and circulatory physiology.

Pulmonary arterial hypertension with plexogenic arteriopathy in enzyme‐substituted Gaucher disease

M. D. den Bakker, C. Hollak, A. Boonstra, 2012, Histopathology.